Congress at a Glance
Scientific Programme
Satellite Programme
Maps of the Venue
Search in:
 Papers, Programme or All
 Please use only plain characters
 (e.g., e, o, c and not è, ö or ç)
 		 
   
  Author   or    Free text  
   
  Author list  

  Personal Planner:
  Create a new login and password click here
Nb. Only your Personal Planner login is valid!
  Username Password  
   
 
  


Track:
  Treatment track
  Clinical research track
  Interface track
  Preclinical track
  Educational updates track

 
Scientific Programme Track:
View last minute changes Last minute changes
Back to overview
14:00-16:05 , Tuesday, 02 September 2008
Symposia   

14:00-16:05
S.21:    Treatment track
Early intervention in schizophrenia: rationale and treatment options
Chairs:  Uriel Heresco-Levy, Israel
  Marc Laruelle, United Kingdom
Auditorium

14:00
S.21.01  Cognition-enhancing interventions as early treatment in schizophrenia  Paper: S.21.01
Robert W. Buchanan, USA
 

14:25
S.21.02  Antipsychotic drugs in the treatment of adolescents with first episode psychosis
Celso Arango, Spain
 

14:50
S.21.03  Antipsychotic intervention in subjects at risk for schizophrenia  Paper: S.21.03
Stephan Ruhrmann, Germany
 

15:15
S.21.04  Early intervention with antidepressant drugs in schizophrenia  Paper: S.21.04
Christoph Correll, USA
 

15:40
S.21.05  The role of NMDAR neurotransmission modulators in the early treatment of schizophrenia  Paper: S.21.05
Uriel Heresco-Levy, Israel
 

14:00-16:05 View last minute changes
S.22:    Clinical research track
PTSD: from initial trauma to the delivery of treatment
Chairs:  Roger Pitman, USA
  Dan J. Stein, South Africa
Dan J. Stein, South Afrika will be replace by Barbara Sahakian, United Kingdom
Room J

14:00
S.22.01  From traumatic events to symptoms: a prospective-longitudinal investigation in the community  Paper: S.22.01
Hans-Ulrich Wittchen, Germany
 

14:25
S.22.02  Fear: acquisition, extinction and reconsolidation
Roger Pitman, USA
 

14:50
S.22.03  Brain imaging and PTSD  Paper: S.22.03
Eric Vermetten, The Netherlands
 

15:15
S.22.04  Comparison of prolonged exposure to cognitive therapy and SSRI's efficacy in acute PTSD  Paper: S.22.04
Arieh Y. Shalev, Israel
 

15:40
S.22.05  Trauma-related disorders and suicide in the French WHO study "Santé Mentale en Population Générale"  Paper: S.22.05
Louis Jehel, France
 

14:00-16:05
S.23:    Interface track
Pharmacological and other challenges for understanding affective and stress-related disorders
Chairs:  Marcus Munafò, United Kingdom
  Koen Schruers, The Netherlands
Room M

14:00
S.23.01  Antidepressants and emotional processing  Paper: S.23.01
Catherine Harmer, United Kingdom
 

14:25
S.23.02  Bipolar disorder  Paper: S.23.02
Adriaan Honig, The Netherlands
 

14:50
S.23.03  CO2 models in anxiety disorders  Paper: S.23.03
Giampaolo Perna, Italy
 

15:15
S.23.04  PharmacoMRI challenge tests  Paper: S.23.04
Ian Anderson, United Kingdom
 

15:40
S.23.05  Neurotransmitter challenges in nicotine addiction  Paper: S.23.05
Brian Hitsman, USA
 

14:00-16:05
S.24:    Preclinical track
Neurosteroids
Chairs:  Giovanni Biggio, Italy
  A. Leslie Morrow, USA
Room F

14:00
S.24.01  Neurosteroids: endogenous modulators of GABA-A receptor  Paper: S.24.01
Jeremy J. Lambert, United Kingdom
 

14:25
S.24.02  Chronic stress changes neurosteroids content and neuronal plasticity in the rat brain  Paper: S.24.02
Giovanni Biggio, Italy
 

14:50
S.24.03  Neuroactive steroids as enhancers of neuroregeneration  Paper: S.24.03
Michael Schumacher, France
 

15:15
S.24.04  Neuroactive steroids in affective disorders  Paper: S.24.04
Cornelius Schüle, Germany
 

15:40
S.24.05  Neurosteroids mediate alcohol sensitivity: mechanisms and therapeutic relevance  Paper: S.24.05
A. Leslie Morrow, USA
 

Scientific café